EUVIMED · CrossrefJournal
The Lancet Child & Adolescent Health
ISSN 2352-4642 · Elsevier BV
Latest articles
Calling for a strategic shift in drug development for childhood cancers
Health service use of young people after mental health admission far from home: a retrospective cohort study in England
Opportunities for advancing paediatric medical device access: regulatory frameworks in the EU and USA
Urban informal settlements: an overlooked context for adolescent digital safety
Growth patterns of children with congenital Zika syndrome in Brazil: a matched-cohort study
Outcomes of hepatic artery thrombosis after paediatric liver transplantation (HEPATIC): an international, multicentre, retrospective registry study
Mental health and urinary incontinence in childhood
Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial
Paediatric liver transplantation: the risk of hepatic artery thrombosis
Growing up with congenital Zika syndrome
Protecting children from meningitis: maintaining momentum
Treatment duration is one stewardship decision in the management of suspected neonatal early-onset sepsis
Treatment duration is one stewardship decision in the management of suspected neonatal early-onset sepsis – Authors' reply
Drug development for childhood cancers
Drug development for childhood cancers
Drug development for childhood cancers
Drug development for childhood cancers – Authors' reply
A safe home for every child and adolescent
Correction to Lancet Child Adolesc Health 2026; 10: 573–83
Correction to Lancet Child Adolesc Health 2026; 10: 552–61
Global reference values for daily steps in preschool children (SUNRISE): a cross-sectional analysis from 44 countries
Acquired cytomegalovirus in children: pathogen, bystander, or immune trainer?
Incidence and predictors of suboptimal functional outcomes despite successful reperfusion in paediatric stroke: a cohort study from the Save ChildS Pro registry
Mechanical thrombectomy outcomes in childhood stroke
Digital readiness, not age: youth social media policy needs a developmental approach
Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6–9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Pharmacological treatment of patent ductus arteriosus and mortality risk in preterm infants: a Bayesian meta-analysis across gestational age groups
Pragmatic, randomised patent ductus arteriosus treatment trials: the end of an era?
From tokenism to co-governance: operationalising youth leadership in global health across 56 Commonwealth nations
Advancing health-care access to optimise health and quality of life for children and young people with Down syndrome worldwide
EUVIMED